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Impact of neonatal resuscitation 
changes on outcomes of 
very‑low‑birth‑weight infants
So Jin Yoon, Joohee Lim, Jung Ho Han, Jeong Eun Shin, Ho Seon Eun, Min Soo Park, 
Kook In Park & Soon Min Lee*
The improvement of delivery room care, according to the 2015 International Consensus, may affect 
neonatal outcome, especially in very‑low‑birth‑weight infants. We aimed to investigate the current 
practice of neonatal resuscitation by year and analyze the association with neonatal outcomes. A 
total of 8142 very‑low‑birth‑weight infants, registered in the Korean Neonatal Network between 2014 
and 2017 were included. A significant decreasing trend of intubation (64.5% vs 55.1%, P < 0.0001) 
and markedly increasing trend of positive pressure ventilation (PPV) (11.5% vs 22.9%, P < 0.0001) 
were noted. The annual PPV rate differed significantly by gestation (P < 0.0001). The highest level 
of resuscitation was also shown as an independent risk factor for mortality within 7 days and 
for bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and periventricular 
leukomalacia. PPV and intubation were associated with significantly decreased risk of mortality and 
morbidities compared to epinephrine use. When considering association, the incidence of mortality 
within 7 days, IVH, PVL, and BPD or mortality showed significant differences by combination of 
year, gestational age, and level of resuscitation. According to updated guidelines, changes in the 
highest level of resuscitation significantly associated with reducing mortality and morbidities. More 
meticulous delivery room resuscitation focusing on extreme prematurity is needed.
The majority of very-low-birth-weight infants (VLBWI) require respiratory assistance at birth, although even the 
most extremely premature infants can breathe or cry at birth. Adequate respiratory support can help improve the 
aeration of the lungs and circulatory  transition1. The risk of mortality is the highest immediately after birth, with 
25–45% of neonatal mortality occurring during the first 24 h after  birth2. Delivery room (DR) care for preterm 
infants is important and is referred to as the golden hour  care3.
The International Liaison Committee on Resuscitation (ILCOR) was formed in 1992 to identify and review 
international science and information relevant to cardiopulmonary resuscitation (CPR) and to establish consen-
sus on treatment recommendations. The 2015 International Consensus on neonatal resuscitation was published 
to identify several unclear and contentious DR resuscitation  issues4.
The increasing intensity of DR resuscitation has been associated with increasing mortality and neurodevelop-
mental impairment in  VLBWI5–8. In a cohort of extremely-low-birth-weight infants (ELBWI) from the Neonatal 
Research Network centers, infants who received chest compressions and/or epinephrine in the DR (DR-CPR) 
had increased risk of grade 3–4 intraventricular hemorrhage (IVH), bronchopulmonary dysplasia (BPD), death 
within 12 h, and neurodevelopmental impairment in survivors at 18 months of corrected  age9. A recent study 
by the Canadian Neonatal Network reported that in ELBWI, DR-CPR was associated with higher mortality or 
neurodevelopmental impairment and lower motor scores at 18–24 months of corrected  age10. In the Vermont 
Oxford Network, survival was reported to be 53.8% with DR-CPR compared with 74.9% without DR-CPR, and 
severe IVH was observed in 15.3% with DR-CPR compared with 4.9% without DR-CPR7. Higher intensity of 
resuscitation was associated with increased risks of mortality, IVH, and periventricular leukomalacia (PVL)5.
In Korea, almost all VLBWI (91.7%) require resuscitation at birth, whereas chest compressions and epineph-
rine administration are required in only 5.4% and 4.1%, respectively. DR-CPR resulted in higher mortality within 
7 days and increased incidence of IVH, PVL, and necrotizing enterocolitis (NEC) compared to PPV  alone11. 
However, the association of different intensities of resuscitation in the DR and neonatal morbidity according 
to the updated neonatal resuscitation guidelines has not been elucidated. In this study, we aimed to investigate 
annual changes in the practice of neonatal resuscitation in Korea according to the new 2015 International Con-
sensus and to analyze the association of the type and nature of resuscitation with short-term outcomes.
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Results
Maternal and neonatal characteristics of 8142 VLBWI according to the year are shown in Table 1. Annual dis-
tributions according to sex, gestational age (GA), birth weight, and small-for-gestational-age (SGA) status were 
not significantly different. The incidence of antenatal steroid use, maternal chorioamnionitis, pregnancy-induced 
hypertension, maternal diabetes, and cesarean delivery significantly increased according to the year. Surfactant 
use in the DR increased from 2014 to 2016 but decreased in 2017.
The annual trend for the highest level of resuscitation in the DR is shown in Fig. 1. A total of 735 (9.0%) 
patients received routine care without resuscitation; 729 (9.0%), only oxygen supplementation; 1359 (16.7%), PPV 
without intubation, chest compressions, and epinephrine use; 4895 (60.1%), intubation without chest compres-
sions and epinephrine use; 145 (1.8%), chest compressions without epinephrine use; and 279 (3.4%) received 
epinephrine. According to the year, the incidence of intubation without compressions markedly decreased (64.5% 
vs 55.1%) (P < 0.0001) and that of PPV gradually increased from 2014 to 2017 (11.5% vs 22.9%) (P < 0.0001).
In multivariate logistic regression analysis (Table 2), the highest level of resuscitation was identified as an inde-
pendent risk factor for mortality within 7 days. GA, Apgar score at 5 min, maternal chorioamnionitis, antenatal 
steroid use, and SGA status were also independent risk factors. Especially, PPV (adjusted odds ratio [aOR], 0.27) 
and endotracheal intubation (aOR, 0.37) were associated with a significantly decreased risk of mortality within 
7 days compared to epinephrine use. The highest level of resuscitation was also identified as an independent 
risk factor for BPD, IVH, and PVL in addition to GA, Apgar score at 5 min, and/or SGA status, and surfactant 
use. Endotracheal intubation and PPV were associated with a significantly decreased risk of BPD, IVH, and 
PVL compared to epinephrine use. Overall, the highest level of resuscitation was significantly associated with 
sepsis (P < 0.0001) and retinopathy of prematurity (ROP) (P = 0.0019); however, the aOR among each level of 
resuscitation compared to epinephrine use showed a partially significant association.
Table 1.  Demographics and outcome of the very-low-birth-weight infants. PIH pregnancy-induced 
hypertension, SGA small for gestational age, DR delivery room, BPD bronchopulmonary dysplasia, IVH 
intraventricular hemorrhage, PVL periventricular leukomalacia, NEC necrotizing enterocolitis, ROP 
retinopathy of prematurity, SD standard deviation. a Mean ± SD.
Total (N = 8142) 2014 (N = 1917) 2015 (N = 2178) 2016 (N = 2134) 2017 (N = 1913) P value
Gestational age(weeks)a 28.5 ± 2.7 28.4 ± 2.7 28.4 ± 2.7 28.5 ± 2.7 28.5 ± 2.7 0.197
 < 25, n (%) 915 (11.2) 213 (11.1) 234 (10.7) 243 (11.4) 225 (11.8)
25–26+6, n (%) 1484 (18.2) 381 (19.9) 429 (19.7) 368 (17.2) 306 (16.0)
27–28+6, n (%) 2044 (25.1) 472 (24.6) 569 (26.1) 515 (24.1) 488 (25.5)
29–30+6, n (%) 2150 (26.4) 473 (24.7) 562 (25.8) 582 (27.3) 533 (27.9)
 ≥ 31, n (%) 1549 (19.0) 378 (19.7) 384 (17.6) 426 (20.0) 361 (18.9)
Birth weight(g)a 1064 ± 287 1060 ± 288 1059 ± 285 1071 ± 288 1066 ± 287 0.556
 < 500, n (%) 198 (2.4) 45 (2.3) 57 (2.6) 56 (2.6) 40 (2.1)
500–749, n (%) 1183 (14.5) 285 (14.9) 311 (14.3) 300 (14.1) 287 (15.0)
750–999, n (%) 1880 (23.1) 450 (23.5) 497 (22.8) 474 (22.2) 459 (24.0)
1000–1249, n (%) 2224 (27.3) 502 (26.2) 636 (29.2) 575 (26.9) 511 (26.7)
1250–1499, n (%) 2657 (32.6) 635 (23.9) 677 (31.1) 729 (34.2) 616 (32.2)
Male, n (%) 4179 (51.3) 951 (49.6) 1124 (51.6) 1142 (53.5) 962 (50.3) 0.064
Cesarean delivery, n (%) 6335 (77.8) 1424 (74.3) 1694 (77.8) 1693 (79.3) 1524 (79.7)  < 0.0001
Apgar score at 1  mina 4.6 ± 2.0 4.6 ± 2.0 4.4 ± 2.0 4.8 ± 2.0 4.6 ± 2.1  < 0.0001
Apgar score at 5  mina 6.8 ± 1.9 6.8 ± 1.8 6.7 ± 1.9 6.9 ± 1.8 6.8 ± 1.9 0.006
Rupture of membrane, n (%) 3030 (37.5) 745 (39.2) 787 (36.4) 796 (37.5) 702 (37.0) 0.306
Chorioamnionitis, n (%) 2480 (36.5) 541 (33.7) 644 (35.6) 687 (38.0) 608 (38.6) 0.012
PIH, n (%) 1527 (18.8) 353 (18.4) 392 (18.0) 399 (18.7) 383 (20.0)  < 0.0001
Maternal diabetes, n (%) 661 (8.1) 135 (7.0) 153 (7.0) 180 (8.4) 193 (10.1) 0.002
Prenatal steroid, n (%) 6655 (82.8) 1477 (78.0) 1718 (80.1) 1802 (85.3) 1658 (88.0)  < 0.0001
SGA, n (%) 1356 (16.8) 313 (16.4) 364 (16.8) 352  (16.7) 327 (17.2) 0.931
Surfactant use in DR, n (%) 2775 (56.5) 664 (56.8) 785 (57.7) 735 (57.7) 591 (53.5) 0.139
BPD(≥ moderate), n (%) 2130 (30.4) 484 (29.4) 548 (28.9) 544 (30.0) 554 (33.5) 0.014
IVH (≥ grade 3), n (%) 753 (9.6) 214 (11.6) 196 (9.4) 189 (9.2) 154 (8.4) 0.006
PVL, n (%) 614 (7.9) 158 (8.7) 157 (7.5) 139 (6.8) 160 (8.7) 0.071
NEC, n (%) 563 (7.0) 120 (6.3) 135 (6.2) 166 (7.8) 142 (7.5) 0.093
Sepsis, n (%) 1774 (21.9) 421 (22.0) 453 (20.8) 464 (21.9) 436 (22.9) 0.467
ROP, n (%) 823 (11.8) 196 (11.9) 214 (11.3) 212 (11.8) 201 (12.2) 0.874
Mortality in 7 days, n (%) 536 (6.6) 127 (6.6) 145 (6.7) 152 (7.1) 112 (5.9) 0.443
Mortality, n (%) 1190 (14.6) 279 (14.6) 303 (13.9) 336 (15.7) 272 (14.2) 0.139
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The serial PPV trends over year differed significantly according to the GA group (P < 0.0001). A generalized 
estimating equation model revealed that the intubation rate differed according to the GA subgroups and year 
(P = 0.01). Post-hoc analysis revealed that the intubation rate markedly decreased in 2016 compared to that in 
2014, especially in infants with a GA ≥ 27 weeks. This rate also decreased in 2017 compared to that in 2014 among 
infants with GA ≥ 25 weeks. The incidence of chest compressions and epinephrine use showed significant differ-
ences only on stratification according to the GA subgroup but not on stratification according to the year (Fig. 2).
The association among the outcomes (mortality within 7 days, BPD or mortality, severe IVH, and PVL) 
according to the level of resuscitation and within effects (GA subgroup and the year of 2014 and 2017 which 
included before and after changes of guideline) is shown in Fig. 3. Mortality within 7 days, IVH, PVL, combined 
mortality and BPD showed significant differences when considering the combination effects of the year, GA, and 
the level of resuscitation. According to the GA subgroup, mortality within 7 days showed significant differences 
the combination of the level of resuscitation and year, especially in the infants with GA < 25 weeks. IVH showed 
significant differences the combination of the level of resuscitation and year, especially in the infants with GA 
27–28 and 29–30 weeks.
Figure 1.  Trends in the highest level of resuscitation in the delivery room. Data are presented as percentage 
values.
Table 2.  Analysis of the risk factors for morbidity in 7 days, BPD, IVH, and PVL using multivariable 
mixed regression model. Only statistically significant variables (P < 0.05) are shown as adjusted odds ratio 
(95% confidential intervals). BPD bronchopulmonary dysplasia, IVH intraventricular hemorrhage, PVL 
periventricular leukomalacia. a Gestational age ≥ 31 weeks is the reference level. b Epinephrine use is the 
reference level.
Mortality in 7 days BPD IVH PVL
Gestational age (week)a
  < 25 20.10(9.30–43.42) 27.36(18.5–40.47) 21.07(11.16–39.75) 1.56(1.02–2.38)
25–26+6 7.23(3.39–15.44) 12.23(8.99–16.64) 8.86(4.77–16.44) 1.59(1.09–2.33)
27–28+6 3.65(1.70–7.84) 5.37(4.01–7.18) 4.25(2.29–7.86) 1.16(0.80–1.68)
29–30+6 2.19(1.00–4.76) 3.12(2.36–4.12) 1.70(0.90–3.20) 1.05(0.73–1.50)
Apgar score at 5 min 0.80(0.75–0.85) 0.84(0.81–0.88) 0.89(0.85–0.94) 0.92(0.87–0.97)
Highest level of resuscitationb
 Routine care 0.17(0.05–0.51) 0.32(0.18–0.56) 0.44(0.21–0.94) 0.46(0.24–0.87)
Oxygen supplementation 0.03(0.004–0.26) 0.26(0.15–0.44) 0.19(0.08–0.46) 0.50(0.28–0.90)
Positive pressure ventilation 0.27(0.14–0.50) 0.37(0.23–0.60) 0.46(0.27–0.78) 0.54(0.33–0.9)
Endotracheal intubation 0.37(0.25–0.55) 0.59(0.38–0.92) 0.61(0.41–0.91) 0.65(0.43–0.99)
Chest compression 0.27(0.13–0.57) 0.75(0.40–1.42) 0.85(0.47–1.57) 1.19(0.65–2.16)
Chorioamnionitis 0.62(0.48–0.79)
Small for gestational age 1.66(1.16–2.39) 2.56(2.05–3.19)
Prenatal steroid 0.55(0.42–0.71)
Surfactant use 1.53(1.17–2.00) 1.96(1.30–2.94)
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Discussion
To the best of our knowledge, this is the first study to analyze trends in resuscitation at the DR in VLBWI and the 
effect on neonatal outcomes, according to the new 2015 International Consensus on neonatal resuscitation. This 
study showed the admirable progress of trends in DR resuscitation. Furthermore, changes in the practice of the 
highest resuscitation level especially increasing PPV and decreasing endotracheal intubation were significantly 
associated with mortality within 7 days and morbidities, such as IVH, PVL and combined mortality with BPD, 
when considering the effects of gestation and the year before and after the guideline changes. Although the 
limitation applying the cause and effect directly, this study suggests that improving the quality of resuscitation 
at the DR may contribute toward the decreased incidence of major morbidities and early mortality. However, 
continued work to improve resuscitation in the DR at the lower gestational ages will be needed.
The Vermont Oxford Network states that 9.3% of infants weighing 401–500 g and 6% of those weighing 
501–1500 g received chest compressions (82.1%) or epinephrine (66.7%).7 Our data are consistent with this 
statement, as 89.1% of the infants in our study received PPV; 71.5%, intubation; 5.4%, chest compressions; and 
3.8%, epinephrine. Other studies reported that 2.0% of extremely preterm infants received chest compressions 
and/or epinephrine in the DR and that the rates of mortality, IVH, and ROP were significantly  higher11. In the 
current study, the highest level of resuscitation was an independent risk factor for mortality within 7 days and 
for IVH, BPD, and PVL.
Through the years, a change in ventilation strategies has been noted, such that proper ventilation with con-
tinuous positive airway pressure was originally emphasized rather than initial  intubation12–14. Noninvasive venti-
lation was preferred for long-term favorable outcome. In this study, a significantly decreasing trend of intubation 
without compressions from 2014 to 2017 (76.6% vs 65%) was noted. PPV without intubation rate changed from 
11.5% in 2014 to 22.9% in 2017 (P < 0.001). However, this intubation rate is higher than that reported in other 
neonatal networks, such as 65% compared to 88% for infants with a GA < 28  weeks15. The Korean National Health 
Insurance guideline for reimbursing prophylactic surfactant administration in premature infants of < 30 weeks’ 
GA at delivery, applied since 2009, could have led to the high incidence of intubation at  delivery16. In the pre-
sent study, prophylactic surfactant administration in the DR with elective intubation of premature infants of 
GA < 30 weeks was practiced in 56.5% of the cases, and there was no significant difference according to the year 
Figure 2.  Trends in the highest level of resuscitation in the delivery room stratified by gestational age. The 
graph shows (A) positive pressure ventilation, (B) intubation, (C) chest compressions, and (D) epinephrine 
use in VLBWI with GA < 25 weeks (purple), 25–26 weeks (yellow), 27–28 weeks (green), 29–30 weeks (red), 
and 31–33 weeks (blue). GA gestational age, wks weeks, VLBWI very-low-birth-weight infants. *P value < 0.05, 
compared with rate in 2014. †P value < 0.05, compared with rate in 2014, by GA subgroup analysis.
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(P = 0.139). Since 2019, noninvasive surfactant administration has been initiated and applied within insurance 
coverage; this appears to be a promising strategy to decrease the incidence of intubation at delivery.
Our study showed that the incidence of extensive resuscitation, including chest compressions and/or epi-
nephrine use, has not changed significantly; however, the intubation rate has decreased and the PPV rate has 
increased yearly. The difference in the intubation rates between 2014 and 2016 was especially prominent. ILCOR 
published updated neonatal resuscitation guidelines in 2015. The Korean Neonatal Society has held the Neona-
tal Resuscitation Program (NRP) workshop yearly and introduced the updated information on NRP to many 
hospital faculties involved in infant delivery. In 2015, the initial use of CPAP rather than intubation and IPPV 
was recommended, and education of best practices is emphasized in the NRP workshops in Korea. Our results 
reflected that neonatologists in Korea have applied the updated guidelines in the DR effectively. However, the 
infants with a higher GA showed apparent changes, and it was still difficult to confirm significant changes in 
infants with GA < 25 weeks. In the future, the application of the new guidelines should focus on strategies to 
improve the outcomes for infants with GA < 25 weeks.
Despite the application of several ventilation strategies, BPD, which is the most common chronic respiratory 
complication in VLBWI, showed increasing incidence due to the increased survival of  ELBWI15. To address the 
prevention of BPD in ELBWI, noninvasive ventilator use and noninvasive surfactant administration in the DR 
are currently being  investigated12,17. In this study, the annual BPD rate was increasing from 2014 to 2016. The 
highest level of resuscitation was confirmed as a significant independent risk factor for BPD.
Moreover, there was a significant difference in the risk of BPD between PPV and intubation at the year before 
and after guideline changes. Further quality improvement projects on resuscitation may lead to a decreasing 
BPD rate.
Mortality within 7 days of birth showed significant differences according to the GA and decreased in the lower 
level of resuscitation group. Antenatal steroid exposure has been reported as a protective factor for  survival18–20. 
In this study, prenatal steroid use increased from 78.0% in 2014 to 88% in 2017; however, after adjusting for 
confounding factors, the highest level of resuscitation was also shown as a significant risk factor for mortality 
within 7 days. (P < 0.0001).
IVH and PVL are important morbidities and may lead to impaired long-term neurodevelopmental outcome. 
According to the California Perinatal Quality Care Collaborative, a decrease in the IVH rate in infants with a GA 
of 22–31 weeks was associated with changes in antenatal steroid exposure and DR  intubation21. In the present 
study, after adjusting for confounding factors, we found that a higher level of resuscitation increased the IVH or 
PVL rates however, antenatal steroid use did not have association.
Figure 3.  Incidence of neonatal outcome versus gestational age and year according to the highest level of 
resuscitation in the delivery room. The graph shows (A) Mortality in 7 days, (B) BPD or death, (C) IVH, 
(D) PVL in VLBWI by GA, and year stratified on PPV (black), intubation(white), and CC + epi(gray). BPD 
bronchopulmonary dysplasia, IVH intraventricular hemorrhage, PVL periventricular leukomalacia, VLBWI 
very-low-birth-weight infants, GA gestational age, wks weeks, PPV positive pressure ventilation, CC chest 
compression, epi epinephrine use, NRP neonatal resuscitation program.
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A major strength of our study is that the Korean Neonatal Network included over 70% of VLBWI cared for 
in neonatal intensive care units in Korea. This information can be extended as a nationwide report on changes 
in the level of resuscitation and outcomes according to the updated NRP guidelines. The analysis of our study 
considered the association effects of GA, year and level of resuscitation, and confounding factors such as maternal 
disease and antenatal care. Therefore, the influence of the level of resuscitation on the neonatal outcomes can 
be well defined.
Our study carries some limitations. There is a limitation applying the cause and effect directly to explain 
the highest level of resuscitation in the DR and mortality/morbidities. Although epinephrine is associated with 
increased mortality and morbidities, PPV and endotracheal intubation do not necessarily be explained as the 
cause of decreasing mortality and morbidities. The data were collected via electronic case report forms; therefore, 
some NRP methods may be up for interpretation. Furthermore, the recording of the highest level of resuscita-
tion may be confusing. A wide spectrum of aggressiveness in the management of periviable infants exists across 
hospitals. Although in 2015, the updated NRP guidelines were revealed and neonatologists and nurses who were 
in-charge of DR resuscitation were immediately instructed to adhere to these guidelines in Korea, there may be 
inter-center variation, inter-personal variation, and time gap for the application of the new guidelines. Several 
factors at delivery room to be related with neonatal outcomes, such as delay cord clamping, initial FiO2, and the 
use of humidified heated gases, were not considered. In addition, this study cannot consider other respiratory 
and nutritional factors relating mortality and morbidities in detail during admission.
In conclusion, the highest level of resuscitation was closely related to mortality and morbidities. According 
to updated guidelines, changes in the resuscitation pattern also significantly contribute to the mortality and 
morbidities. Efforts to meticulously update the resuscitation guidelines for extreme preterm infants in delivery 
room will be promising to improve the outcomes.
Methods
Subject population. Data for 9032 VLBWI born between 2014 and 2017 in 55–60 Korean Neonatal Net-
work (KNN) centers were prospectively collected using a standardized electronic case report form. The infants 
with major anomalies and above 34 weeks of GA were excluded. A total of 8142 infants were included in the 
study. The KNN registry was approved by the institutional review boards of all participating hospitals. Informed 
consent forms were signed by the parents of the infants during enrollment in the KNN. The present study was 
performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later 
amendments and was approved by the KNN data management committee and the Gangnam Severance Hospital 
IRB (IRB number 3-2013-0020).
Outcomes and variables. GA was determined according to the best available estimate in weeks and days. 
GA was further classified as follows: < 25 weeks, 25–26 weeks, 27–28 weeks, 29–30 weeks, and 31–33 weeks. DR 
resuscitation, including the use of supplemental oxygen, PPV with face mask and bag or T-piece resuscitator 
without intubation, endotracheal intubation, chest compression, and epinephrine use, was defined as the high-
est level of resuscitation the infants received. Morbidities were defined as follows: BPD (moderate or severe) was 
defined as oxygen use at 36 weeks of postmenstrual  age22; PVL was defined as evidence of PVL on cranial imag-
ing at any time; sepsis was defined by cultures positive for bacteria or fungi and antibiotic therapy ≥ 5  days23,24; 
NEC was defined as clinical and radiographic findings indicating ≥ stage  225; severe IVH was defined as grade 
3 or 4 IVH based on cranial imaging performed before 28 days of  life26; and severe ROP was defined as disease 
stage ≥ 3 or treatment with retinal ablation surgery or anti-vascular endothelial growth factor drug.  For the 
comparison of outcome before and after change of the guideline, the outcomes at 2014 and 2017 were selected.
Statistical analysis. We used one-way analysis of variance and χ2 test to evaluate bivariate associations 
between the characteristics and years. Linear regression models were used to determine whether the change in 
the highest level of resuscitation in the DR was significant. Risk stratification was based on GA or year. A mul-
tivariable mixed regression model using the GLIMMIX procedure was used for risk adjustment to predict the 
factors associated with mortality within 7 days and major morbidities (BPD, severe IVH, sepsis, ROP, and PVL). 
Variables in the model included GA, mode of delivery, prolonged rupture of membranes, histologic chorioam-
nionitis, pregnancy-induced hypertension, receipt of antenatal steroid, surfactant use in the DR, SGA status, 
5-min Apgar score, and the highest level of resuscitation. The logistic regression models predicted mortality 
within 7 days and the presence of BPD, IVH, and/or PVL with interaction effects among the different levels of 
resuscitation, GA, and year. The proportion profile graph was used to show the trends and association among the 
level of resuscitation, GA, and year. All statistical analyses were performed using SAS version 9.4 (SAS Institute, 
Cary, North Carolina). P-values < 0.05 were considered statistically significant.
Data availability
The dataset analyzed in this study are not publicly available due to the policy of Research of Korea Centers for 
Disease Control and Prevention. However, datasets are available from the corresponding author on reasonable 
request.
Received: 25 April 2020; Accepted: 6 April 2021
7
Vol.:(0123456789)
Scientific Reports |         (2021) 11:9003  | https://doi.org/10.1038/s41598-021-88561-5
www.nature.com/scientificreports/
References
 1. Martherus, T. et al. Supporting breathing of preterm infants at birth: A narrative review. Arch. Dis. Child. Fetal Neonatal. Ed. 104, 
F102–F107 (2019).
 2. Baik, N. et al. Ventilation strategies during neonatal cardiopulmonary resuscitation. Front. Pediatr. 6, 18 (2018).
 3. Peleg, B. et al. “Golden Hour” quality improvement intervention and short-term outcome among preterm infants. J. Perinatol. 39, 
387–392 (2019).
 4. Perlman, J. M. et al. Part 7: Neonatal resuscitation: 2015 international consensus on cardiopulmonary resuscitation and emergency 
cardiovascular care science with treatment recommendations. Circulation 132, S204–S241 (2015).
 5. Bajaj, M. et al. Delivery room resuscitation and short-term outcomes in moderately preterm infants. J. Pediatr. 195, 33-38.e2 (2018).
 6. Isayama, T. The clinical management and outcomes of extremely preterm infants in Japan: Past, present, and future. Transl. Pediatr. 
8, 199–211 (2019).
 7. Finer, N. N., Horbar, J. D. & Carpenter, J. H. Cardiopulmonary resuscitation in the very low birth weight infant: The Vermont 
Oxford Network experience. Pediatrics 104, 428–434 (1999).
 8. Wyckoff, M. H. et al. Outcome of extremely low birth weight infants who received delivery room cardiopulmonary resuscitation. 
J. Pediatr. 160, 239-244.e2 (2012).
 9. Chawla, S., Foglia, E. E., Kapadia, V. & Wyckoff, M. H. Perinatal management: What has been learned through the network?. Semin. 
Perinatol. 40, 391–397 (2016).
 10. Fischer, N. et al. Extensive cardiopulmonary resuscitation of preterm neonates at birth and mortality and developmental outcomes. 
Resuscitation 135, 57–65 (2019).
 11. Arnon, S. et al. Delivery room resuscitation and adverse outcomes among very low birth weight preterm infants. J. Perinatol. 37, 
1010–1016 (2017).
 12. Schmolzer, G. M. et al. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-
analysis. BMJ 347, f5980; https:// doi. org/ 10. 1136/ bmj. f5980 (2013).
 13. Petrillo, F. et al. Pulmonary recruitment strategy in preterm neonates < 29 weeks of gestational age to reduce the need for intuba-
tion in the delivery room. Am. J. Perinatol. 36, S115–S119 (2019).
 14. Te Pas, A. B., Hooper, S. B. & Dekker, J. The changing landscape in supporting preterm infants at birth. Neonatology 115, 392–397 
(2019).
 15. Stoll, B. J. et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 314, 1039–1051 
(2015).
 16. Cho, S. J., Shin, J. & Namgung, R. Initial resuscitation at delivery and short term neonatal outcomes in very-low-birth-weight 
infants. J. Korean Med. Sci. 30(Suppl 1), S45–S51 (2015).
 17. Foglia, E. E., Jensen, E. A. & Kirpalani, H. Delivery room interventions to prevent bronchopulmonary dysplasia in extremely 
preterm infants. J. Perinatol. 37, 1171–1179 (2017).
 18. DeMauro, S. B. et al. Impact of delivery room resuscitation on outcomes up to 18 months in very low birth weight infants. J. Pediatr. 
159, 546-550.e1 (2011).
 19. Mori, R., Kusuda, S. & Fujimura, M. Antenatal corticosteroids promote survival of extremely preterm infants born at 22 to 23 
weeks of gestation. J. Pediatr. 159, 110-114.e1 (2011).
 20. Norman, M. et al. Association of short antenatal corticosteroid administration-to-birth intervals with survival and morbidity 
among very preterm infants: Results from the EPICE cohort. JAMA Pediatr. 171, 678–686 (2017).
 21. Handley, S. C., Passarella, M., Lee, H. C. & Lorch, S. A. Incidence trends and risk factor variation in severe intraventricular hemor-
rhage across a population based cohort. J. Pediatr. 200, 24-29.e3 (2018).
 22. Ehrenkranz, R. A. et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. 
Pediatrics 116, 1353–1360 (2005).
 23. Stoll, B. J. et al. Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics 127, 
817–826 (2011).
 24. Stoll, B. J. et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. 
Pediatrics 110, 285–291 (2002).
 25. Walsh, M. C. & Kliegman, R. M. Necrotizing enterocolitis: Treatment based on staging criteria. Pediatr. Clin. N. Am. 33, 179–201 
(1986).
 26. Papile, L. A., Burstein, J., Burstein, R. & Koffler, H. Incidence and evolution of subependymal and intraventricular hemorrhage: a 
study of infants with birth weights less than 1,500 gm. J. Pediatr. 92, 529–534 (1978).
Acknowledgements
This work was supported by the Research Program funded by the Korean Centers for Disease Control and Pre-
vention (2019-ER7103-01#). We thank the members of the Korean Neonatal Network for contribution.
Author contributions
Conceptualization: H.S.E., S.M.L. Methodology: S.M.L., S.J.Y., J.E.S., J.H.L. Software: S.M.L., S.J.Y. Validation: 
J.H.L., J.H.H., J.E.S., H.S.E., M.S.P., K.I.P. Investigation: S.J.Y. Writing—original draft: S.J.Y., S.M.L. Writing, 
reviewing, & editing: S.M.L. Supervision: M.S.P., K.I.P.
Competing interests 
The authors declare no competing interests.
Additional information
Correspondence and requests for materials should be addressed to S.M.L.
Reprints and permissions information is available at www.nature.com/reprints.




Scientific Reports |         (2021) 11:9003  | https://doi.org/10.1038/s41598-021-88561-5
www.nature.com/scientificreports/
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons licence, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/.
© The Author(s) 2021
